Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.447 EUR | -0.67% |
|
-10.00% | -13.96% |
04-11 | Poxel: CDC falls below the 10% threshold | CF |
02-15 | Poxel S.A. Reports Unaudited Revenue Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
121B | ||||||
110B | ||||||
25.98B | - | |||||
19.27B | - | |||||
15.99B |
- Stock Market
- Equities
- POXEL Stock
- 7PO Stock
- Charts Poxel
- Sector Chart